Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Net Margin (2016 - 2025)

Historic Net Margin for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to 118.66%.

  • Sanara MedTech's Net Margin fell 1061900.0% to 118.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 42.65%, marking a year-over-year decrease of 320300.0%. This contributed to the annual value of 11.33% for FY2024, which is 45000.0% down from last year.
  • According to the latest figures from Q3 2025, Sanara MedTech's Net Margin is 118.66%, which was down 1061900.0% from 7.06% recorded in Q2 2025.
  • Over the past 5 years, Sanara MedTech's Net Margin peaked at 1.48% during Q4 2023, and registered a low of 118.66% during Q3 2025.
  • Its 5-year average for Net Margin is 24.95%, with a median of 17.51% in 2024.
  • As far as peak fluctuations go, Sanara MedTech's Net Margin surged by 322300bps in 2023, and later tumbled by -1061900bps in 2025.
  • Quarter analysis of 5 years shows Sanara MedTech's Net Margin stood at 50.57% in 2021, then skyrocketed by 46bps to 27.18% in 2022, then soared by 95bps to 1.48% in 2023, then plummeted by -1694bps to 26.62% in 2024, then tumbled by -346bps to 118.66% in 2025.
  • Its Net Margin stands at 118.66% for Q3 2025, versus 7.06% for Q2 2025 and 14.48% for Q1 2025.